1. Home
  2. Clinical Topics
  3. FDA approves new treatment for rare bile acid synthesis disorders
Clinical TopicsDrugs and DevicesNewsWeb Exclusives

FDA approves new treatment for rare bile acid synthesis disorders

Share

On March 17, the U.S. Food and Drug Administration (FDA) approved Cholbam (cholic acid) capsules, the first FDA-approved treatment for pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, and for patients with peroxisomal disorders (including Zellweger spectrum disorders. Read more.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts